-
Advisers ultimately said sticking with JN.1 rather than its offshoots promises to offer a better chance at cross-protection. The FDA will decide the final recipe soon.
-
The spread of an avian flu virus in cattle has again brought public health attention to the potential for a global pandemic. Fighting it would depend, for now, on 1940s technology that makes vaccines from hens’ eggs.
-
Scare tactics haven’t shifted, but more parents are falling for them. Here’s what the rhetoric gets wrong and how it endangers children.
-
The guidance is in stark contrast to statements by Gov. Ron DeSantis and Florida Surgeon General Dr. Joseph Ladapo against vaccination and mask wearing — particularly when it comes to COVID-19.
-
An expert panel for the CDC endorsed the one-time shot for infants born just before or during the RSV season and for those less than 8 months old before the start of the season.
-
These aren't traditional vaccines that prevent disease, but shots to shrink tumors and stop cancer from coming back. Targets for these experimental treatments include breast and lung cancer.
-
Vaccine experts are excited about new clinical trial results for a device that delivers measles vaccine via a "microarray" patch — no syringe needed.
-
The Vaccines for Children program, which buys more than half the pediatric vaccines in the U.S., may not cover the RSV shot for babies because it’s not technically a vaccine.
-
As COVID has become less virulent, the debate over vaccine mandates has faded. But some workers who were fired for refusing the shots are still fighting to be reinstated.
-
The drugmakers said a combination of the vaccine and Merck’s immunotherapy Keytruda led to a statistically significant improvement in survival before the cancer returned in patients with advanced melanoma.